Methylprednisolone and other confounders to spinal cord injury clinical trials.
Sipski
Marca L
ML
Department of Physical Medicine and Rehabilitation at the University of Alabama, Birmingham 35249-7330, USA. msipski@uab.edu
Pearse
Damien D
DD
D002986:Clinical Trials as Topic; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D013119:Spinal Cord Injuries / Q000188:drug therapy*
D018696:Neuroprotective Agents; D008775:Methylprednisolone